ℹ️
🇬🇧
Search
Search for publications relevant for "Hydrazone bond"
Hydrazone bond
Publication
Class
Person
Publication
Programmes
Export current view
publication
Doxorubicin bound to a HPMA copolymer carrier thrugh hydrazone bond is effective also in a cancer cell line with a limited content of lysosomes
2001 |
First Faculty of Medicine
publication
Doxorubicin bound to a HPMA copolymer carrier thrugh hydrazone bond is effective also in a cancer cell line with a limited content of lysosomes
2001 |
Faculty of Physical Education and Sport
publication
HPMA polymer conjugates with doxorubicin attached via hydrazone bond: improvement of efficacy
Publication without faculty affiliation
publication
Poly(2-ethyl-2-oxazoline) conjugates with doxorubicin for cancer therapy: In vitro and in vivo evaluation and direct comparison to poly[N-(2-hydroxypropyl)methacrylamide] analogues
2017 |
First Faculty of Medicine
publication
Structure-Activity Relationships of Novel Salicylaldehyde Isonicotinoyl Hydrazone (SIH) Analogs: Iron Chelation, Anti-Oxidant and Cytotoxic Properties
2014 |
Faculty of Pharmacy in Hradec Králové
publication
Poly[N-(2-hydroxypropyl)methacrylamide]-Modified Magnetic gamma-F2O3 Nanoparticles Conjugated with Doxorubicin for Glioblastoma Treatment
2020 |
First Faculty of Medicine, Second Faculty of Medicine
publication
Poly[N-(2-hydroxypropyl)methacrylamide]-Modified Magnetic γ-F2O3 Nanoparticles Conjugated with Doxorubicin for Glioblastoma Treatment
2020 |
First Faculty of Medicine, Second Faculty of Medicine
publication
Methyl and ethyl ketone analogs of salicylaldehyde isonicotinoyl hydrazone: Novel iron chelators with selective antiproliferative action
2012 |
Faculty of Pharmacy in Hradec Králové
publication
Fine tuning of the pH-dependent drug release rate from polyHPMA-ellipticinium conjugates
2013 |
First Faculty of Medicine
publication
Overcoming resistance to rituximab in relapsed non-Hodgkin lymphomas by antibody-polymer drug conjugates actively targeted by anti-CD38 daratumumab
2020 |
First Faculty of Medicine
publication
Polymer-ritonavir derivate nanomedicine with pH-sensitive activation possesses potent anti-tumor activity in vivo via inhibition of proteasome and STAT3 signaling
2021 |
Second Faculty of Medicine
publication
Hpma-based copolymers carrying stat3 inhibitor cucurbitacin-d as stimulus-sensitive nanomedicines for oncotherapy
2021 |
Central Library of Charles University
publication
Anti-Lymphoma Efficacy Comparison of Anti-CD20 Monoclonal Antibody-Targeted and Non-Targeted Star-Shaped Polymer-Prodrug Conjugates
2015 |
First Faculty of Medicine
publication
Effective doxorubicin-based nano-therapeutics for simultaneous malignant lymphoma treatment and lymphoma growth imaging
2018 |
First Faculty of Medicine